CRL
Price
$189.59
Change
-$3.31 (-1.72%)
Updated
Oct 3 closing price
26 days until earnings call
ICLR
Price
$293.18
Change
-$1.21 (-0.41%)
Updated
Oct 3 closing price
19 days until earnings call
Ad is loading...

CRL vs ICLR

Header iconCRL vs ICLR Comparison
Open Charts CRL vs ICLRBanner chart's image
Charles River Laboratories International
Price$189.59
Change-$3.31 (-1.72%)
Volume$855.16K
CapitalizationN/A
ICON
Price$293.18
Change-$1.21 (-0.41%)
Volume$725.12K
CapitalizationN/A
View a ticker or compare two or three
CRL vs ICLR Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRL vs. ICLR commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and ICLR is a StrongBuy.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (CRL: $189.59 vs. ICLR: $293.18)
Brand notoriety: CRL and ICLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 110% vs. ICLR: 131%
Market capitalization -- CRL: $13.96B vs. ICLR: $27.35B
CRL [@Medical Specialties] is valued at $13.96B. ICLR’s [@Medical Specialties] market capitalization is $27.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileICLR’s FA Score has 1 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • ICLR’s FA Score: 1 green, 4 red.
According to our system of comparison, CRL is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while ICLR’s TA Score has 5 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 5 bearish.
  • ICLR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ICLR is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -4.37% price change this week, while ICLR (@Medical Specialties) price change was +2.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.03%. For the same industry, the average monthly price growth was +2.95%, and the average quarterly price growth was -3.89%.

Reported Earning Dates

CRL is expected to report earnings on Oct 30, 2024.

ICLR is expected to report earnings on Oct 23, 2024.

Industries' Descriptions

@Medical Specialties (-1.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICLR($27.4B) has a higher market cap than CRL($14B). ICLR has higher P/E ratio than CRL: ICLR (44.81) vs CRL (29.15). ICLR YTD gains are higher at: 3.999 vs. CRL (-18.401). ICLR has higher annual earnings (EBITDA): 1.52B vs. CRL (1.03B). ICLR has more cash in the bank: 380M vs. CRL (277M). CRL has less debt than ICLR: CRL (3.07B) vs ICLR (3.94B). ICLR has higher revenues than CRL: ICLR (8.12B) vs CRL (4.13B).
CRLICLRCRL / ICLR
Capitalization14B27.4B51%
EBITDA1.03B1.52B68%
Gain YTD-18.4013.999-460%
P/E Ratio29.1544.8165%
Revenue4.13B8.12B51%
Total Cash277M380M73%
Total Debt3.07B3.94B78%
FUNDAMENTALS RATINGS
CRL vs ICLR: Fundamental Ratings
CRL
ICLR
OUTLOOK RATING
1..100
5910
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
7530
SMR RATING
1..100
6277
PRICE GROWTH RATING
1..100
6162
P/E GROWTH RATING
1..100
5081
SEASONALITY SCORE
1..100
395

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (70) in the Pharmaceuticals Other industry is in the same range as CRL (74) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew similarly to CRL’s over the last 12 months.

ICLR's Profit vs Risk Rating (30) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRL (75) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew somewhat faster than CRL’s over the last 12 months.

CRL's SMR Rating (62) in the Miscellaneous Commercial Services industry is in the same range as ICLR (77) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

CRL's Price Growth Rating (61) in the Miscellaneous Commercial Services industry is in the same range as ICLR (62) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

CRL's P/E Growth Rating (50) in the Miscellaneous Commercial Services industry is in the same range as ICLR (81) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLICLR
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Bullish Trend 22 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 18 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
68%
N/A
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADTX2.702.59
+2330.24%
Aditxt Inc
SWIN3.340.66
+24.63%
Solowin Holdings Ordinary Share
AMSC21.880.55
+2.58%
American Superconductor Corp
SCL77.510.23
+0.30%
Stepan Co
LEA108.230.11
+0.10%
Lear Corp

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.61%
IQV - CRL
76%
Closely correlated
+0.17%
AZTA - CRL
66%
Closely correlated
+0.46%
TMO - CRL
60%
Loosely correlated
-0.04%
WAT - CRL
59%
Loosely correlated
-0.92%
DHR - CRL
57%
Loosely correlated
-0.24%
More

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with IQV. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+3.47%
IQV - ICLR
65%
Loosely correlated
+0.17%
RGEN - ICLR
62%
Loosely correlated
-1.72%
CRL - ICLR
56%
Loosely correlated
-0.61%
MEDP - ICLR
52%
Loosely correlated
+1.03%
ITGR - ICLR
45%
Loosely correlated
+0.03%
More